Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2016.07.09
金融衍生品生意营业内部控制制度(2016年7月)
2016.07.09
关于公司与花旗银行举行交织钱币掉期生意的通告
2016.07.09
第三届董事会第二十四次聚会决议通告
2016.07.05
关于公司员工持股妄想股票完成出售的通告
2016.06.28
第三届董事会第二十三次聚会决议通告
2016.06.28
关于召开2016年第一次暂时股东大会的通知通告
2016.06.28
关于审计部司理退休的通告
2016.06.23
关于完成工商挂号变换的通告
2016.06.21
关于公司使用自有资金购置低危害理工业品的希望通告
2016.06.17
关于公司使用自有资金对TPG BIOTECHNOLOGY PARTNERS V,L.P.投资的通告
第一页
上一页
84
85
86
87
88
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】